eMurmur Heart AI vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
eMurmur Heart AI focuses on AI-powered analysis of heart and lung sounds for screening and monitoring, utilizing digital stethoscopes. In contrast, Us2.v2 automates the interpretation of echocardiogram images to generate comprehensive reports and detect specific cardiac diseases. While both aim to enhance cardiac diagnostics, they address distinct diagnostic modalities and workflows, making them complementary rather than directly competitive.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
eMurmur Heart AI supports mobile apps and web portals for screening and remote consultation, allowing for live streaming and recording of auscultation data. It is hardware-neutral and stethoscope agnostic, and can be accessed through its standalone software or secure API integration into third-party systems. Us2.v2 integrates seamlessly with existing PACS, CVIS, or EMR systems, supporting HL7 and DICOM SR, and aims to return structured results into the reading and reporting workflow. It automates image labeling, annotation, measurements, and analysis, delivering a full report in 2-3 minutes, which can be returned directly to the cardiology PACS or reporting system.
eMurmur Heart AI automatically analyzes heart and lung sounds, detecting and classifying pathologic and innocent heart murmurs, and providing hemodynamic insights like loudness ratios of S1, systole, S2, and diastole. Studies have shown eMurmur's heart murmur detection algorithm to have a sensitivity of 93% and specificity of 81%, with an overall accuracy of 88% for detecting pathologic cases. Us2.v2 automates echocardiogram interpretation, detecting cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, and provides a complete structured echo report with measurements and clinical findings. Its automated measurements have been validated in peer-reviewed studies against expert readers, showing good to excellent agreement for various parameters and correctly identifying 100% of pulmonary hypertension and severe aortic stenosis cases in a prospective study.
eMurmur Heart AI is well-suited for screening, monitoring, and remote consultation in cardiology, internal medicine, and pulmonology, and has been clinically tested in both adult and pediatric populations, including differentiating between pathologic and physiologic murmurs in children. It complements traditional auscultation by providing objective, AI-powered analysis of heart and lung sounds, which can be particularly useful in primary care settings to reduce unnecessary referrals. Us2.v2, primarily for cardiology, is designed for high-volume settings and multi-vendor environments, streamlining echocardiogram analysis and reporting. It can be used for population-level disease screening by reanalyzing archived echocardiograms to uncover undetected heart failure, cardiac amyloidosis, and other conditions, and supports new clinical pathways in primary care settings by enabling novice screening with AI guidance.
eMurmur Heart AI is described as easy to use with a simple, proven UI and real-time quality assurance algorithms, making it similar to standard auscultation practices. Us2.v2 emphasizes 100% AI automation, eliminating manual frame selection and annotation, which can reduce reporting time by up to 70% and increase daily scan throughput, suggesting a rapid efficiency gain. This automation allows sonographers to focus on more complex tasks and can significantly reduce the overall time to perform echocardiography, leading to a quicker return on investment through improved workflow and increased capacity.
eMurmur Heart AI's mobile app and web portal, along with its hardware-neutral and stethoscope-agnostic compatibility, suggest flexibility for multi-site deployment and remote use. Us2.v2 offers both cloud and on-premise deployment options and integrates with existing PACS, CVIS, or EMR systems, supporting DICOM SR and HL7 for structured results. This allows for seamless integration into diverse IT infrastructures and facilitates data synchronization across a large healthcare system, with the ability to reprocess historical echocardiograms for population-level analysis.